Teladoc (TDOC) stock up 0.39% but lags S&P 500 and Dow, analysts optimistic.

From Nasdaq: 2025-04-02 18:15:00

Teladoc (TDOC) closed at $7.79, up 0.39% from the previous day, but lagged behind the S&P 500 and Dow. The stock has fallen by 15.65% in the past month, underperforming the Medical sector. Teladoc is expected to report earnings of -$0.32 per share, with revenue projected at $617.67 million.

Analyst estimates for Teladoc show optimism, with positive revisions reflecting confidence in the company’s business. The Zacks Rank system, with Teladoc currently at #3 (Hold), has a strong track record of outperforming, with stocks rated #1 producing an average annual return of +25% since 1988. The Zacks Consensus EPS estimate for Teladoc has shifted 2.01% upward.

The Medical Services industry, where Teladoc operates, has a Zacks Industry Rank of 66, in the top 27% of all industries. Zacks Industry Rank analysis shows that top-rated industries outperform lower-ranked ones by a factor of 2 to 1. Investors can stay updated on Teladoc and other stock metrics on Zacks.com.

Looking for potential high-growth stocks? Zacks experts have identified 5 stocks set to double, with previous recommendations soaring by +143.0%, +175.9%, +498.3%, and +673.0%. These picks are under the radar, presenting an opportunity to invest early and potentially see significant gains. Want to know more? Visit Zacks.com for the latest recommendations.



Read more at Nasdaq: Teladoc (TDOC) Gains But Lags Market: What You Should Know